<DOC>
	<DOCNO>NCT00000298</DOCNO>
	<brief_summary>The purpose study determine target dose range buprenorphine/naloxone combination tablet provide therapeutic response opiate addict low moderate dependence , identify appropriate initial induction dose opiate addict low moderate dependence . ''</brief_summary>
	<brief_title>Buprenorphine Combination Tablet Feasibility - 1</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>Males/Females age 2150 , opiate dependence accord DSMIV criterion , selfreported use within last 30 day , agreeable condition study sign informed consent Psychiatric disorder require medication therapy , history seizure , pregnant and/or nursing woman , dependence etoh benzodiazepine sedativehypnotics , acute hepatitis , medical condition deem participation unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 1996</verification_date>
</DOC>